title: Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
abstract: We have reported that serum level of soluble HLA-A, -B, -C (sHLA-A,-B,-C) antigens is elevated in HIV-infected subjects and decreases after antiretroviral therapy (HAART). In this study, we measured the levels of soluble HLA-G (sHLA-G) antigens in a cohort of HIV-infected patients before and during HAART. sHLA-G and sHLA-A, -B, -C levels were significantly elevated in HIV-infected subjects as compared with controls before antiretroviral treatment and significantly decreased after 36 months of HAART. sHLA-G levels were correlated with sHLA-A, -B, -C levels, the decrease of plasma HIV-RNA level, the increase of CD4+ T-lymphocyte number and the decrease of CD8+ T-lymphocyte number. These results suggest that the measurement of sHLA-G and sHLA-A, -B, -C antigen serum levels might represent a useful surrogate marker to monitor virological response and immune reconstitution in HIV-positive subjects undergoing HAART treatment.
authors.affiliation: Department of Internal Medicine, University of Genoa, Genoa, Italy. Giuseppe.Murdaca@unige.it
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Murdaca
authors.forename: Paola
authors.initials: P
authors.lastname: Contini
authors.forename: Maurizio
authors.initials: M
authors.lastname: Setti
authors.forename: Paola
authors.initials: P
authors.lastname: Cagnati
authors.forename: Francesca
authors.initials: F
authors.lastname: Lantieri
authors.forename: Francesco
authors.initials: F
authors.lastname: Indiveri
authors.forename: Francesco
authors.initials: F
authors.lastname: Puppo
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D015415:Biomarkers / Q000097:blood; D018791:CD4 Lymphocyte Count; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D015497:HIV-1 / Q000235:genetics*; D006680:HLA Antigens / Q000097:blood*; D015234:HLA-A Antigens / Q000097:blood*; D015235:HLA-B Antigens / Q000097:blood*; D015236:HLA-C Antigens / Q000097:blood*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000097:blood*; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood / Q000235:genetics; D012727:Sex Characteristics; D016176:T-Lymphocyte Subsets / Q000166:cytology
chemical_list: D015415:Biomarkers; D006680:HLA Antigens; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D015236:HLA-C Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; D012367:RNA, Viral